Table 3.
Imaging Modality | Optimal Use in cSCC | Advantages | Disadvantages | Sensitivity/Specificity for H&N Nodal Disease a |
---|---|---|---|---|
CT | Bone or lymph node disease | Less expensive, more widely available, and faster image acquisition than MRI | Exposure to contrast dye and ionizing radiation | 52%/93% |
MRI | Perineural, CNS, deep soft tissue, BM, or lymph node disease | No exposure to ionizing radiation | Less widely available, longer acquisition time, more expensive than CT | 65%/81% |
US | Superficial lymph node disease and image-guided FNA | Least expensive, no exposure to contrast dye or ionizing radiation, rapid image acquisition, global accessibility | Operator and technique-dependent, limited visualization of deep structures | 66%/78% |
PET/CT | Distant metastases | Functional and anatomic information, distinguishes postoperative scar tissue from recurrence | Most expensive, lesions less than 10 mm are below resolution for FDG-PET | 66%/87% |
BM, bone marrow; CNS, central nervous system; cSCC, cutaneous squamous cell carcinoma; CT, computed tomography; FDG, fluorodeoxyglucose; FNA, fine needle aspiration; H&N, head and neck; MRI, magnetic resonance imaging; PET, positron emission tomography; US, ultrasonography. a Adapted from Liao et al., 2012 [39].